Clinical Trial Update: Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy

View source ↗

Summary

The clinical trial investigating MRI of tumor response and cognitive impairment in breast cancer patients receiving chemotherapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Kettering Health Network | Conditions: Breast Cancer | Status: WITHDRAWN